TY - JOUR
T1 - Imaging-guided pre-dilatation, stenting, post-dilatation
T2 - a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds
AU - Ali, Ziad A.
AU - Karimi Galougahi, Keyvan
AU - Shlofmitz, Richard
AU - Maehara, Akiko
AU - Mintz, Gary S.
AU - Abizaid, Alexandre
AU - Chamié, Daniel
AU - Hill, Jonathan
AU - Serruys, Patrick W.
AU - Onuma, Yoshinobu
AU - Stone, Gregg W.
N1 - Publisher Copyright:
© 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/6/3
Y1 - 2018/6/3
N2 - Introduction: The advent of the fully bioresorbable vascular scaffold (BVS) is the latest step in a series of advancements in the design of intracoronary stents over the past few decades. The novelty of this technology is in providing temporary vessel scaffolding and local antiproliferative therapy to prevent neointimal hyperplasia after percutaneous coronary intervention followed by gradual resorption of the scaffold to restore the native vessel anatomy and physiology–a process termed vascular reparative therapy. Areas covered: The first generation of BVS has not been able to fully match the high benchmark in safety and efficacy set by contemporary metallic drug-eluting stents. These shortcomings of BVS may be due to factors related to the device itself, the complexity of the underlying lesion, or the implantation technique. Expert commentary: Here, how intravascular imaging may be used to minimize these shortcomings is described and moreover, an imaging-guided step-by-step approach for BVS implantation that integrates the recently described pre-dilatation, stenting, post-dilatation (PSP) strategy is explained.
AB - Introduction: The advent of the fully bioresorbable vascular scaffold (BVS) is the latest step in a series of advancements in the design of intracoronary stents over the past few decades. The novelty of this technology is in providing temporary vessel scaffolding and local antiproliferative therapy to prevent neointimal hyperplasia after percutaneous coronary intervention followed by gradual resorption of the scaffold to restore the native vessel anatomy and physiology–a process termed vascular reparative therapy. Areas covered: The first generation of BVS has not been able to fully match the high benchmark in safety and efficacy set by contemporary metallic drug-eluting stents. These shortcomings of BVS may be due to factors related to the device itself, the complexity of the underlying lesion, or the implantation technique. Expert commentary: Here, how intravascular imaging may be used to minimize these shortcomings is described and moreover, an imaging-guided step-by-step approach for BVS implantation that integrates the recently described pre-dilatation, stenting, post-dilatation (PSP) strategy is explained.
KW - bioresorbabale scaffold
KW - drug-eluting stent
KW - Intravascular imaging
KW - intravascular ultrasound
KW - optical coherence tomography
UR - https://www.scopus.com/pages/publications/85047559746
U2 - 10.1080/14779072.2018.1473034
DO - 10.1080/14779072.2018.1473034
M3 - Review article
C2 - 29732926
AN - SCOPUS:85047559746
SN - 1477-9072
VL - 16
SP - 431
EP - 440
JO - Expert Review of Cardiovascular Therapy
JF - Expert Review of Cardiovascular Therapy
IS - 6
ER -